However, more clinical and experimental investigations are still needed for a better understanding of the role of WRAP53 and its transcripts in the mechanisms involved in tumorigenesis so that it may be addressed as potential new biomarker in cancer and a target in the development of new treatments. This evidence concerns the gene WRAP53 and cancer.